Biotech Business - January 8, 2018
Cytovation completes financing round of 30 million NOK
Cytovation has raised NOK 10m in a private funding round, completing the second stage of fundraising, having raised NOK 20m in June 2017. Both financings were led by a group of private investors in Norway and the company will now use these funds to advance lead product CyPep-H1 through the final stages of pre-clinical development and […]
In a new job - January 23, 2017
New Scientific Advisor at Cytovation
Cytovation AS, a privately held biotech company developing CyPep-1 for the treatment of skin disorders announces the appointment of Professor Ole-Erik Iversen as Scientific Advisor. Professor Iversen has been Professor of Gynecology & Obstetrics at University of Bergen since 1992, having previously held positions at the Department of Surgery at Molde Hospital; the Department of […]
In a new job - October 3, 2016
Cytovation announces new appointments
Norwegian Cytovation, a privately held biotech company developing CyPep-1 for the treatment of skin disease, announces the appointment of two key members to the Cytovation team. Raj Airey joins as Venture Developer. He is a venture developer and investor with extensive experience in health sector and senior leadership roles with-in blue chip multi-nations like Pfizer and Baxter. […]
